Boston Scientific Corporation ($BSX) Stock Forecast: Up 1.5% Today

What is Boston Scientific Corporation?

Boston Scientific (BSX) is a leading medical technology company that manufactures medical devices used in interventional medical specialties. The company is known for its innovative products in areas such as cardiology, endoscopy, and neuromodulation.

Why is Boston Scientific Corporation going up?

BSX stock is up 1.5% on Sep 2, 2025 14:42

• BSX had a strong bullish movement today, potentially driven by the company's consistent outperformance in the market over the past 5 years, with an average annual return of 20.59%.
• The comparison with other medical stocks may have highlighted BSX's strong performance, attracting investors looking for growth opportunities in the sector.
• Investors might be optimistic about BSX's future prospects, considering its track record of innovation and market leadership in the medical technology industry.

BSX Price Chart

BSX Technical Analysis

BSX News

Are Medical Stocks Lagging Boston Scientific ( BSX ) This Year?

Here is how Boston Scientific (BSX) and Allarity Therapeutics, Inc. (ALLR) have performed compared to their sector so far this year.

https://www.zacks.com/stock/news/2744765/are-medical-stocks-lagging-boston-scientific-bsx-this-year

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today - Boston Scientific ( NYSE:BSX )

Boston Scientific BSX has outperformed the market over the past 5 years by 7.61% on an annualized basis producing an average annual return of 20.59%. Currently, Boston Scientific has a market capitalization of $156.41 billion.

https://www.benzinga.com/insights/news/25/08/47402598/if-you-invested-100-in-this-stock-5-years-ago-you-would-have-this-much-today

Trending Today

Aave ($AAVE) Crypto Forecast: Down 5.2% Today

Ondo ($ONDO) Crypto Forecast: Down 5.3% Today

Dogecoin ($DOGE) Crypto Forecast: Down 5.3% Today

Affirm Holdings Inc. ($AFRM) Stock Forecast: Up 5.2% Today

Illumina Inc. ($ILMN) Stock Forecast: Up 5.2% Today

Tilray Inc. ($TLRY) Stock Forecast: Up 5.3% Today

Shoals Technologies Group Inc. ($SHLS) Stock Forecast: Up 5.1% Today

Duolingo Inc. ($DUOL) Stock Forecast: Down 5.0% Today

Teleflex Incorporated ($TFX) Stock Forecast: Down 5.1% Today

Opendoor Technologies Inc. ($OPEN) Stock Forecast: Down 8.1% Today

Boston Scientific Corporation Price History

24.06.2025 - BSX Stock was down 1.9%

• BSX reported strong Q2 earnings, exceeding estimates and raising its full-year outlook.
• Despite the positive earnings, the stock saw a bearish movement, possibly due to profit-taking by investors who had already factored in the positive news.
• The market's negative reaction may stem from concerns about BSX's ability to maintain its growth momentum in the future, leading some investors to sell off their positions.
• Broader market conditions or sector-specific factors could have influenced the bearish movement in BSX, despite the favorable earnings report.

04.03.2025 - BSX Stock was down 5.4%

• BSX stock saw a -1.55% decline, ending the day at $98.50.
• The stock has been consistently decreasing, with a 3.16% drop in the current session and a 1.95% decrease over the past month.
• Despite a 44.16% rise over the last year, investors are questioning whether BSX presents a better value proposition compared to other stocks in the Medical Products sector.
• The recent bearish movement seems to stem from profit-taking following significant prior gains, as investors reevaluate the company's value and growth potential vis-à-vis competitors like Phibro Animal Health (PAHC).

08.00.2025 - BSX Stock was up 5.2%

• Boston Scientific's recent acquisition of Bolt Medical for over $440 million has expanded its cardiovascular treatment portfolio, showcasing growth and innovation in its offerings.
• Achieving a 52-week high reflects strong investor confidence and indicates potential for further gains going forward.
• Despite market fluctuations, Boston Scientific's resilience and positive performance highlight its strength and attractiveness to investors.
• The ongoing sales growth in endoscopy operations beyond the U.S. demonstrates Boston Scientific's adeptness in navigating competition and sustaining a competitive advantage in the market.

25.01.2025 - BSX Stock was down 3.2%

• Despite Boston Scientific's positive outlook for 2025 with expected strong revenue growth, the market might have reacted negatively due to concerns about potential challenges or uncertainties in achieving these ambitious targets.
• Investors may have been expecting even higher growth projections or may have been disappointed by other factors not mentioned, leading to the bearish movement in BSX stock.
• It's possible that profit-taking or a broader market correction influenced the stock's decline, overshadowing the positive expectations for the company's performance in the near future.

02.06.2025 - BSX Stock was down 2.5%

• BSX, having outpaced market performance recently, saw a downturn in its stock value.
• Comparisons to peers such as PAHC and MDT may have contributed to investor apprehension about BSX's future trajectory.
• Intensified competition from Medtronic within the MedSurg segment potentially prompted doubts regarding BSX's market stance and growth opportunities.
• Investors appeared to revisit their perspectives on BSX's value proposition, resulting in today's bearish market activity.

10.03.2025 - BSX Stock was up 7.5%

• BSX stock surged 6.8% in a bullish movement today.
• The positive price movement could be attributed to the market's optimism about the company's future growth prospects.
• Despite a recent drop in share price and earnings estimate revisions, investors seem to be confident in BSX's long-term potential, possibly driven by successful product developments or strategic partnerships.
• The overall bullish sentiment towards BSX today may indicate that investors believe in the company's ability to deliver strong financial performance in the coming periods.

02.08.2025 - BSX Stock was up 1.5%

• BSX had a strong bullish movement today, potentially driven by the company's consistent outperformance in the market over the past 5 years, with an average annual return of 20.59%.
• The comparison with other medical stocks may have highlighted BSX's strong performance, attracting investors looking for growth opportunities in the sector.
• Investors might be optimistic about BSX's future prospects, considering its track record of innovation and market leadership in the medical technology industry.

06.07.2025 - BSX Stock was down 2.2%

• The bearish movement in BSX today could be attributed to investors comparing the stock with GE HealthCare Technologies (GEHC) and potentially finding more value in the latter.
• The overly optimistic views of Wall Street analysts on BSX might have raised concerns among investors about the stock's actual performance, leading to a sell-off.
• Investors may have also reacted to broader market trends or specific industry news impacting medical product companies, causing a negative sentiment towards BSX in today's trading session.

23.03.2025 - BSX Stock was up 5.5%

• BSX stock demonstrated significant bullish momentum recently.
• The company disclosed Q1 earnings and revenues that exceeded expectations, signaling robust financial results.
• Market participants seem to be responding favorably to the strong performance, displaying trust in Boston Scientific's potential for growth.
• The impressive earnings and revenue figures are likely fueling heightened investor confidence and enthusiasm for the stock, contributing to its current upward trajectory.

23.03.2025 - BSX Stock was up 5.5%

• Boston Scientific Corporation (BSX) raised its annual outlook after reporting strong sales in heart devices in Q1, beating revenue and earnings estimates.
• The company's cardiovascular sales saw significant growth, particularly in cardiology products, which contributed to the overall positive performance.
• The stock price surged as investors reacted positively to the company's robust Q1 earnings and revenue results, leading to an optimistic outlook for the future.
• Boston Scientific's solid product portfolio and financial performance in Q1 2025 have instilled confidence in investors, driving the stock price higher.

07.02.2025 - BSX Stock was down 5.1%

• The decline in BSX stock was influenced by doubts surrounding the excessively positive views from Wall Street, causing investors to question the stock's true value and associated risks.
• Despite acquiring SoniVie for $400 million to enhance its hypertension treatment portfolio, there are concerns about the impact on BSX's 2025 EPS, possibly affecting its short-term financial performance and outlook.
• Market uncertainties about integrating SoniVie into Boston Scientific's operations and realizing the expected benefits might be driving a cautious investor sentiment.

10.03.2025 - BSX Stock was down 5.3%

• Analysts view BSX as a promising investment, yet the stock saw a decline, possibly linked to investors capitalizing on profits.
• Following a notable increase in BSX's share price in the previous session, today's drop suggests a shift in market sentiment.
• The stock price of BSX declined by 1.55%, potentially due to investors seizing the opportunity to secure profits following the recent upsurge.